Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.88K Buy
16
+1
+7% +$115 ﹤0.01% 195
2026
Q1
$1.65K Hold
15
﹤0.01% 176
2025
Q4
$1.65K Buy
15
+4
+36% +$441 ﹤0.01% 177
2025
Q3
$1.23K Buy
11
+1
+10% +$105 ﹤0.01% 207
2025
Q2
$1.05K Sell
10
-5
-33% -$525 ﹤0.01% 206
2025
Q1
$1.67K Buy
15
+10
+200% +$1.06K ﹤0.01% 166
2024
Q4
$517 Buy
5
+1
+25% +$109 ﹤0.01% 170
2024
Q3
$447 Buy
4
+1
+33% +$102 ﹤0.01% 191
2024
Q2
$268 Buy
3
+1
+50% +$86 ﹤0.01% 232
2024
Q1
$172 Buy
+2
New +$164 ﹤0.01% 257
2022
Q1
Sell
-7
Closed -$438 158
2021
Q4
$408 Buy
+7
New +$392 ﹤0.01% 171
2021
Q3
Hold
0
166
2021
Q2
Hold
0
172

Other funds holding AFL

WestEnd Advisors's AFL Position: Q2 2026 in Review

WestEnd Advisors increased its Aflac (AFL) stake by 6.7% in Q2 2026, buying an estimated $115 and bringing the position to 16 shares worth $1.88K. The position accounts for ﹤0.01% of the portfolio, ranked #195.

WestEnd Advisors first reported a position in AFL in Q4 2021 and has held it in 11 quarters since. 1,693 funds tracked by Wall St. Rank hold AFL as of Q2 2026.

  • WestEnd Advisors held 16 shares of Aflac worth $1.88K as of Q2 2026.
  • WestEnd Advisors bought 1 Aflac share in Q2 2026, an estimated $115.
  • Aflac made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #195 holding.
  • WestEnd Advisors first reported a position in Aflac in Q4 2021 and has held it in 11 quarters since.
  • 1,693 funds tracked by Wall St. Rank held Aflac as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.